These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1107462)

  • 21. Effects of continuous LHRH infusion on plasma levels of LH and FSH in males, before and after oestrogen or anti-oestrogen treatment.
    van Bergeijk L; Gooren LJ; van Kessel H; Sassen AM
    Horm Metab Res; 1986 Aug; 18(8):558-64. PubMed ID: 3093351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The control of deviant sexual behaviour by drugs. I. Behavioural changes following oestrogens and anti-androgens.
    Bancroft J; Tennent G; Loucas K; Cass J
    Br J Psychiatry; 1974 Sep; 125(0):310-5. PubMed ID: 4607733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of low doses of cyproterone acetate on sperm morphology and some other parameters of reproduction in normal men.
    Fredricsson B; Carlström K
    Andrologia; 1981; 13(4):369-75. PubMed ID: 6456681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low estrogen doses normalize testosterone and estradiol levels to the female range in transgender women.
    Cunha FS; Domenice S; Sircili MHP; Mendonca BB; Costa EMF
    Clinics (Sao Paulo); 2018; 73():e86. PubMed ID: 29723345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A; Gallardo E
    Fertil Steril; 1991 May; 55(5):877-81. PubMed ID: 1827074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The evaluation of the role of androgens in hirsutism and the use of a new anti-androgen "cyproterone acetate" for therapy.
    Ismail AA; Davidson DW; Souka AR; Barnes EW; Irvine WJ; Kilimnik H; Vanderbeeken Y
    J Clin Endocrinol Metab; 1974 Jul; 39(1):81-95. PubMed ID: 4835125
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
    Wallace EM; Gow SM; Wu FC
    J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some effects of treatment with ethinyl oestradiol with or without polyoestradiol phosphate in patients with prostatic carcinoma.
    Tomić R
    Scand J Urol Nephrol; 1986; 20(3):193-6. PubMed ID: 3097813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Annual variation in semen characteristics and plasma hormone levels in men undergoing vasectomy.
    Reinberg A; Smolensky MH; Hallek M; Smith KD; Steinberger E
    Fertil Steril; 1988 Feb; 49(2):309-15. PubMed ID: 3123279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
    Tomić R
    Scand J Urol Nephrol Suppl; 1983; 77():1-37. PubMed ID: 6426040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: Sex-hormone-binding globulin, luteinizing hormone and testosterone in man: effects of oestrogen and cyproterone acetate.
    Murray MA; Anderson DC; Bancroft JH; Tennant TG; Carr PJ
    J Endocrinol; 1973 Nov; 59(2):xxi-xxii. PubMed ID: 4759619
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of idiopathic hirsute women with two combinations of cyproterone acetate.
    Salva P; Morer F; Ordoñez J; Rodriguez J
    Int J Clin Pharmacol Res; 1983; 3(2):129-35. PubMed ID: 6237068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Behavior of LH, FSH, total testosterone, free testosterone and SHBG serum levels in the therapy of prostatic cancer with Turisteron (ethinyl estradiol sulfonate)].
    Guddat HM; Schnorr D; Dörner G; Stahl F; Rohde W
    Z Urol Nephrol; 1987 Dec; 80(12):665-8. PubMed ID: 3126615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum luteinizing hormone pulsatility and intratesticular testosterone and oestradiol concentrations in idiopathic infertile men with high and normal follicle stimulating hormone serum concentrations.
    Levalle OA; Zylbersztein C; Aszpis S; Mariani V; Ponzio R; Aranda C; Guitelman A; Scaglia HE
    Hum Reprod; 1994 May; 9(5):781-7. PubMed ID: 7929722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of sex-hormone-binding globulin in hormonal changes and amenorrhoea in thyrotoxic women.
    Akande EO; Anderson DC
    Br J Obstet Gynaecol; 1975 Jul; 82(7):557-61. PubMed ID: 50080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.
    Koch UJ; Lorenz F; Danehl K; Ericsson R; Hasan SH; Keyserlingk DV; Lübke K; Mehring M; Römmler A; Schwartz U; Hammerstein J
    Contraception; 1976 Aug; 14(2):117-35. PubMed ID: 949890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.